Quality of Life and Exercise Capacity in COPD

• Sponsor: Izmir Katip Celebi University (Other)
• Overall Status: Completed
• CT.gov ID: NCT04376892
• Collaborator: (none)
• Enrollment: 516
• Actual Duration (Months): 88

Study Details

Study Description

Brief Summary

COPD patients will be examined in 4 groups according to their walking distance. Patients walking under 150 meters will be determined as Group 1, those walking between 150-249 meters will be Group 2, those walking between 250-349 meters will be selected as Group 3, and patients with COPD who walk 350 and above will be determined as Group 4. The groups were compared in terms of quality of life, psychological symptoms and dyspnea.

Condition or Disease	Intervention/Treatment	Phase
Copd; Quality of Life; Exercise Capacity	Other: Quality of life measurement

Detailed Description

Quality of life affects the mortality rate independently in patients with COPD. The treatment applied in COPD does not stop the decrease in lung function, nor does it prolong the survival time. Spirometric evaluations to determine the severity of the disease are not sufficient to explain the perception of patients and their adaptation to their diseases. Therefore, evaluating the quality of life has become an important measure of treatment in COPD patients. Quality of life measurements should be done to minimize the effect of the disease, to help patients better cope with the consequences of an incurable long-term condition, and to determine modifiable factors. Identifying modifiable factors; in personalized treatment adopted in airway diseases in recent years; it is important to be able to apply appropriate pharmacological and non-pharmacological treatments Our aim is to exercise capacity in COPD patients; firstly to investigate the effect on quality of life, then to determine the relationship between emergency admission and hospitalization, dyspnea, psychological symptoms.

Study Design

• Study Type: Observational
• Actual Enrollment: 516 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: The Effect of Exercise Capacity on Quality of Life in COPD Patients
• Actual Study Start Date: Jan 1, 2013
• Actual Primary Completion Date: Sep 1, 2019
• Actual Study Completion Date: May 1, 2020

Arms and Interventions

Arm	Intervention/Treatment
Group 1 Exercise capacity under 149 meter	Other: Quality of life measurement; Quality of life measurement by St. George Respiratory questionnaire
Group 2 Exercise capacity between 150 and 249 meter	Other: Quality of life measurement; Quality of life measurement by St. George Respiratory questionnaire
Group 3 Exercise capacity between 250 and 349 meter	Other: Quality of life measurement; Quality of life measurement by St. George Respiratory questionnaire
Group 4 Exercise capacity above 340	Other: Quality of life measurement; Quality of life measurement by St. George Respiratory questionnaire

Outcome Measures

Primary Outcome Measures

1. Quality of life questionnaire [20 minutes]

   St. George Respiratory Questionnaire

Secondary Outcome Measures

1. Dyspnea Severity [5 minutes]

   mMRC

2. Respiratory Function [20 minutes]

   Respiratory Function Test

3. Anxiety Depression [20 minutes]

   Hospital anxiety and Depression Qustionnaire

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• COPD patients completed all tests and qustionnaires

Exclusion Criteria:

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Izmir Katip Celebi University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Ilknur Naz, Assoc. Prof., Izmir Katip Celebi University
• ClinicalTrials.gov Identifier: NCT04376892
• Other Study ID Numbers: IKCU2
• First Posted: May 6, 2020
• Last Update Posted: May 6, 2020
• Last Verified: May 1, 2020

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Ilknur Naz, Assoc. Prof., Izmir Katip Celebi University: copd; quality of life; exercise capacity

Study Results

No Results Posted as of May 6, 2020